2-Amino-5-methoxypyridine | CAS:10167-97-2

We serve 2-Amino-5-methoxypyridine CAS:10167-97-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Amino-5-methoxypyridine
Chemical Name:2-Amino-5-methoxypyridine
CAS.NO:10167-97-2
Synonyms:5-methoxypyridin-2-amine; 5-Methoxy-Pyridin-2-Ylamine;
Molecular Formula:C6H8N2O
Molecular Weight:124.14100
 
Physical and Chemical Properties:
Density:1.139;
Boiling point:251.6oC;
Flash point:106oC;
Index of Refraction:1.56;
 
Specification:
Appearance:Dark brown liquid
Purity:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 2-Amino-5-methoxypyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Methoxy-Pyridin-2-Ylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-methoxypyridin-2-amine Use and application,5-Methoxy-Pyridin-2-Ylamine technical grade,usp/ep/jp grade.


Related News: What are the symptoms? Coronavirus symptoms can look like the flu — fever, cough, trouble breathing. If you show these symptoms and recently went to China, or have been in contact with someone who visited, experts advise going to the doctor.Iminostilbene N-Carbonyl Chloride manufacturer What are the symptoms? Coronavirus symptoms can look like the flu — fever, cough, trouble breathing. If you show these symptoms and recently went to China, or have been in contact with someone who visited, experts advise going to the doctor.D-Phenylalanine supplier Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.4-Pyridinylboronic Acid vendor Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.